Subtopic Deep Dive

← Economic and Financial Impacts of Cancer

Productivity Costs of Cancer
Research Guide

What is Productivity Costs of Cancer?

Productivity costs of cancer quantify indirect economic losses from work absenteeism, reduced labor output, premature mortality, and caregiver burdens due to cancer incidence and treatment.

This subtopic evaluates societal impacts beyond direct medical costs using methods like human capital approaches and friction cost methods. Key studies include Hanly and Sharp (2014) measuring lost productivity from premature cancer mortality (74 citations). Over 20 papers in the provided lists address related economic burdens, with foundational work in cost-utility analyses (Greenberg et al., 2010, 181 citations).

Curated Papers

Key Challenges

Why It Matters

Productivity cost assessments reveal cancer's full economic toll, informing policy on prevention and support programs; Hanly and Sharp (2014) estimate premature mortality costs as a major burden component. Landwehr et al. (2016) show young adult survivors face financial toxicity from lost income and savings depletion (94 citations), affecting treatment adherence. These evaluations guide resource allocation in health systems, as seen in de Oliveira et al. (2016) phase-specific cost analyses including indirect losses (123 citations).

Key Research Challenges

Valuing Lost Productivity

Quantifying intangible losses from absenteeism and presenteeism requires standardized methods amid varying labor markets. Hanly and Sharp (2014) apply human capital methods to mortality but note sensitivity to wage assumptions. Friction cost alternatives undervalue long-term impacts in low-employment settings.

Caregiver Burden Measurement

Isolating caregiver productivity losses from patient effects demands longitudinal data often unavailable. Landwehr et al. (2016) highlight young adult cancer's ripple effects on family finances. Studies like Goldsbury et al. (2018) link survival to costs but overlook informal caregiving (114 citations).

Cross-Country Comparability

Economic models differ by healthcare systems and employment rates, complicating global benchmarks. Wu et al. (2012) compare treatments in resource-limited settings, showing context-specific cost-effectiveness (106 citations). Greenberg et al. (2010) review CUAs revealing methodological heterogeneity across oncology interventions (181 citations).

Essential Papers

Pricing in the Market for Anticancer Drugs

David H. Howard, Peter B. Bach, Ernst R. Berndt et al. · 2015 · The Journal of Economic Perspectives · 436 citations

In 2011, Bristol-Myers Squibb set the price of its newly approved melanoma drug ipilimumab—brand name Yervoy—at $120,000 for a course of therapy. The drug was associated with an incremental increas...

Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer

Naomi Y. Ko, Susan Hong, Robert A. Winn et al. · 2020 · JAMA Oncology · 198 citations

This study's findings suggest that nearly half of the observed racial/ethnic disparities in higher stage at breast cancer diagnosis are mediated by health insurance coverage.

When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology

Dan Greenberg, Craig C. Earle, Chi-Hui Fang et al. · 2010 · JNCI Journal of the National Cancer Institute · 181 citations

New cancer treatments pose a substantial financial burden on health-care systems, insurers, patients, and society. Cost-utility analyses (CUAs) of cancer-related interventions have received increas...

Phase-specific and lifetime costs of cancer care in Ontario, Canada

Claire de Oliveira, Reka Pataky, Karen E. Bremner et al. · 2016 · BMC Cancer · 123 citations

The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview

Catherine Duggan, Allison Dvaladze, Anne F. Rositch et al. · 2020 · Cancer · 122 citations

Background The Breast Health Global Initiative (BHGI) established a series of resource‐stratified, evidence‐based guidelines to address breast cancer control in the context of available resources. ...

Health services costs for cancer care in Australia: Estimates from the 45 and Up Study

David Goldsbury, Sarsha Yap, Marianne Weber et al. · 2018 · PLoS ONE · 114 citations

Lung cancer healthcare costs are strongly associated with survival-related factors. Costs appeared stable over the period 2006-2013. This study provides a framework for evaluating the health/econom...

The promise of Immuno-oncology: implications for defining the value of cancer treatment

Howard L. Kaufman, Michael B. Atkins, Prasun Subedi et al. · 2019 · Journal for ImmunoTherapy of Cancer · 111 citations

The rapid development of immuno-oncology (I-O) therapies for multiple types of cancer has transformed the cancer treatment landscape and brightened the long-term outlook for many patients with adva...

Reading Guide

Foundational Papers

Start with Greenberg et al. (2010) for cost-utility frameworks (181 citations), then Hanly and Sharp (2014) for mortality productivity methods (74 citations), as they establish core valuation approaches.

Recent Advances

Study Landwehr et al. (2016) on young adult financial impacts (94 citations) and de Oliveira et al. (2016) phase-specific costs (123 citations) for contemporary indirect loss estimates.

Core Methods

Human capital (lifetime earnings), friction cost (replacement time), willingness-to-pay; integrated in CUAs (Greenberg et al., 2010; Hanly and Sharp, 2014).

How PapersFlow Helps You Research Productivity Costs of Cancer

Discover & Search

Research Agent uses searchPapers and exaSearch to find productivity cost papers like 'The cost of lost productivity due to premature cancer-related mortality' by Hanly and Sharp (2014), then citationGraph reveals 74 citing works on indirect costs. findSimilarPapers expands to caregiver burden studies from Landwehr et al. (2016).

Analyze & Verify

Analysis Agent applies readPaperContent to extract valuation methods from Hanly and Sharp (2014), then runPythonAnalysis recreates human capital cost models with NumPy/pandas on mortality data for statistical verification. verifyResponse (CoVe) with GRADE grading assesses evidence quality in cost-utility claims from Greenberg et al. (2010).

Synthesize & Write

Synthesis Agent detects gaps in productivity valuation across demographics via contradiction flagging on Landwehr et al. (2016) young adult data, then Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to generate LaTeX reports with exportMermaid diagrams of cost flows. Gap detection highlights underexplored caregiver metrics.

Use Cases

"Compute productivity losses from cancer mortality using Hanly 2014 methods on recent US data"

Research Agent → searchPapers (Hanly 2014) → Analysis Agent → readPaperContent + runPythonAnalysis (pandas human capital model) → CSV export of age/wage-adjusted losses.

"Draft LaTeX section comparing productivity costs in young adults vs general population"

Synthesis Agent → gap detection (Landwehr 2016 vs Goldsbury 2018) → Writing Agent → latexEditText + latexSyncCitations + latexCompile → formatted PDF with cost comparison table.

"Find code for friction cost vs human capital models in cancer economics papers"

Research Agent → paperExtractUrls (Hanly 2014) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for model replication.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ papers on productivity costs, chaining searchPapers → citationGraph → GRADE grading for structured report on valuation methods. DeepScan applies 7-step analysis with CoVe checkpoints to verify Hanly and Sharp (2014) mortality estimates against de Oliveira et al. (2016). Theorizer generates hypotheses on caregiver productivity integration from Landwehr et al. (2016) literature.

Try Doxa for Productivity Costs of Cancer Research

Frequently Asked Questions

What defines productivity costs of cancer?

Indirect losses from absenteeism, reduced output, mortality, and caregiving, valued via human capital or friction cost methods (Hanly and Sharp, 2014).

What are main valuation methods?

Human capital approach sums lifetime earnings lost to mortality; friction cost method values time to replace worker (Hanly and Sharp, 2014; Greenberg et al., 2010).

What are key papers?

Foundational: Hanly and Sharp (2014, 74 citations) on mortality costs; Greenberg et al. (2010, 181 citations) on cost-utility. Recent: Landwehr et al. (2016, 94 citations) on young adults.

What open problems exist?

Standardizing caregiver burden metrics and cross-country adjustments; underexplored presenteeism in low-resource settings (Landwehr et al., 2016; Wu et al., 2012).